Cryos Technologies Inc. is pleased to announce that it has received its class 2 medical device licence from Health Canada for its BioVizion, non-invasive medical imaging system. This is the last remaining regulatory requirement clearing the way to commence the marketing of BioVizion in Canada.

Cryos Technologies Inc. is pleased to announce that it has successfully completed the ISO 13485-2003 accreditation process for its BioVizion non-invasive medical imaging system. This accreditation was completed in accordance with the requirement stipulated by Health Canada in its medical device licensing program.